These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

903 related items for PubMed ID: 15818703

  • 1. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N, Juillet F, Garnero P.
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [Abstract] [Full Text] [Related]

  • 2. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P, Gineyts E, Christgau S, Finck B, Delmas PD.
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [Abstract] [Full Text] [Related]

  • 3. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
    Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, Delmas PD.
    Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
    [Abstract] [Full Text] [Related]

  • 4. Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations.
    Rousseau JC, Chevrel G, Schott AM, Garnero P.
    Bone; 2010 Apr; 46(4):897-900. PubMed ID: 20005316
    [Abstract] [Full Text] [Related]

  • 5. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, Emery P, Poole AR, Veale DJ.
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.
    Jansen NW, Roosendaal G, Lundin B, Heijnen L, Mauser-Bunschoten E, Bijlsma JW, Theobald M, Lafeber FP.
    Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938
    [Abstract] [Full Text] [Related]

  • 15. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis.
    Kong SY, Stabler TV, Criscione LG, Elliott AL, Jordan JM, Kraus VB.
    Arthritis Rheum; 2006 Aug; 54(8):2496-504. PubMed ID: 16868970
    [Abstract] [Full Text] [Related]

  • 16. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
    Sharif M, Kirwan JR, Elson CJ, Granell R, Clarke S.
    Arthritis Rheum; 2004 Aug; 50(8):2479-88. PubMed ID: 15334461
    [Abstract] [Full Text] [Related]

  • 17. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments.
    Ishikawa T, Nishigaki F, Christgau S, Noto T, Mo J, From N, Minoura K, Hirayama Y, Ohkubo Y, Mutoh S.
    J Rheumatol; 2004 Jun; 31(6):1174-9. PubMed ID: 15170932
    [Abstract] [Full Text] [Related]

  • 18. Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis.
    Jung M, Christgau S, Lukoschek M, Henriksen D, Richter W.
    Pathobiology; 2004 Jun; 71(2):70-6. PubMed ID: 14707441
    [Abstract] [Full Text] [Related]

  • 19. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
    Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E.
    Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
    [Abstract] [Full Text] [Related]

  • 20. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.
    Garnero P, Cloos P, Sornay-Rendu E, Qvist P, Delmas PD.
    J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.